Pacira | PCRX - Ebit


Pacira reported $3.19M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Astellas Pharma JPY 134.54B 30.13B Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Cara Therapeutics USD -5.94M 3.55M Sep/2025
Coherus Biosciences USD -39.08M 3.65M Dec/2025
Heron Therapeutics USD 38K 3.83M Dec/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
J&J USD 5.11B 2.3B Dec/2025
Ligand Pharmaceuticals USD 158.89M 115.32M Sep/2025
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Omeros USD -48.15M 7.25M Sep/2023
Pacira USD 3.19M 9.96M Dec/2025
Perrigo USD 84.4M 9M Dec/2025
Pfizer USD 4.65B 71M Dec/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025
Xeris Pharmaceuticals USD 16.77M 8.88M Dec/2025
Xoma USD -10.08M 4.4M Jun/2024
Zoetis USD 835M 140M Dec/2025